Futura Medical PLC (AIM:FUM, OTC:FAMDF) has announced Jeff Needham as its new non-executive chair, succeeding from John Clarke who has stepped down.
Clarke joined Futura in 2011 and, in a statement, the company described him as instrumental in driving the Company's strategy and success in securing commercial partnerships.
Needham has been on the Futura board since October 2021 and he is being appointed as chair as part of a planned transition.
Futura noted that the board change comes as the company continues its progress in a pivotal year of success in broadening the distribution and availability of the MED3000 product across different markets, worldwide.
"Following yesterday's announcement of the company's US collaboration with global leading consumer healthcare company, Haleon, and as the company enters its next stage of growth, it is the appropriate time for me, after twelve years to move on,” Clarke said.
“It has been a privilege to work with the Futura team, seeing transformational progress, growth and execution.
“Achieving FDA approval for our lead product MED3000 was a critical focus for me as chairman, significantly de-risking MED3000 and allowing the company to negotiate a US commercialisation deal that would make MED3000 available to consumers in the largest ED market worldwide.”
James Barder, Futura chief executive, added: “As the commercialisation of MED3000 continues to gather pace in the US and globally, we are fortunate to have a natural successor on the board.
“Jeff's extensive experience and expertise with the consumer healthcare products industry, in particular in the US market, will be invaluable as Futura enters an exciting new chapter in its development."